Zalcberg JR - Search Results

1

Altered expression of the IGF-1 receptor in a tamoxifen-resistant human breast cancer cell line.

Parisot JP, Hu XF, DeLuise M, Zalcberg JR. Parisot JP, et al. Among authors: zalcberg jr. Br J Cancer. 1999 Feb;79(5-6):693-700. doi: 10.1038/sj.bjc.6690112. Br J Cancer. 1999. PMID: 10070856 Free PMC article.

2

Circumvention of doxorubicin resistance in multi-drug resistant human leukaemia and lung cancer cells by the pure antioestrogen ICI 164384.

Hu XF, Nadalin G, De Luise M, Martin TJ, Wakeling A, Huggins R, Zalcberg JR. Hu XF, et al. Among authors: zalcberg jr. Eur J Cancer. 1991;27(6):773-7. doi: 10.1016/0277-5379(91)90187-i. Eur J Cancer. 1991. PMID: 1648945

3

Rapid functional assay for multidrug resistance in human tumor cell lines using the fluorescent indicator fluo-3.

Wall DM, Hu XF, Zalcberg JR, Parkin JD. Wall DM, et al. Among authors: zalcberg jr. J Natl Cancer Inst. 1991 Feb 6;83(3):206-7. doi: 10.1093/jnci/83.3.206. J Natl Cancer Inst. 1991. PMID: 1988706 No abstract available.

4

Effect of cyclosporin and verapamil on the cellular kinetics of daunorubicin.

Hu XF, de Luise M, Martin TJ, Zalcberg JR. Hu XF, et al. Among authors: zalcberg jr. Eur J Cancer. 1990;26(7):814-7. doi: 10.1016/0277-5379(90)90159-q. Eur J Cancer. 1990. PMID: 2145901

5

Combined use of cyclosporin A and verapamil in modulating multidrug resistance in human leukemia cell lines.

Hu XF, Martin TJ, Bell DR, de Luise M, Zalcberg JR. Hu XF, et al. Among authors: zalcberg jr. Cancer Res. 1990 May 15;50(10):2953-7. Cancer Res. 1990. PMID: 2334897

6

Cellular and karyotypic characterization of two doxorubicin resistant cell lines isolated from the same parental human leukemia cell line.

Zalcberg JR, Hu XF, Wall DM, Mirski S, Cole S, Nadalin G, De Luise M, Parkin JD, Vrazas V, Campbell L, et al. Zalcberg JR, et al. Int J Cancer. 1994 May 15;57(4):522-8. doi: 10.1002/ijc.2910570414. Int J Cancer. 1994. PMID: 7514153

7

The pure antiestrogen ICI 182,780 binds to a high-affinity site distinct from the estrogen receptor.

Parisot JP, Hu XF, Sutherland RL, Wakeling A, Zalcberg JR, DeLuise M. Parisot JP, et al. Among authors: zalcberg jr. Int J Cancer. 1995 Aug 9;62(4):480-4. doi: 10.1002/ijc.2910620420. Int J Cancer. 1995. PMID: 7635575

8

Quality of pharmacokinetic research in oncology.

Siderov J, Brien JE, Morgan DJ, Zalcberg J, Cosolo W. Siderov J, et al. Br J Cancer. 1995 Sep;72(3):792-4. doi: 10.1038/bjc.1995.413. Br J Cancer. 1995. PMID: 7669597 Free PMC article.

9

Rapid up-regulation of mdr1 expression by anthracyclines in a classical multidrug-resistant cell line.

Hu XF, Slater A, Wall DM, Kantharidis P, Parkin JD, Cowman A, Zalcberg JR. Hu XF, et al. Among authors: zalcberg jr. Br J Cancer. 1995 May;71(5):931-6. doi: 10.1038/bjc.1995.180. Br J Cancer. 1995. PMID: 7734315 Free PMC article.

10

Differential effects of estrogen, tamoxifen and the pure antiestrogen ICI 182,780 in human drug-resistant leukemia cell lines.

Zalcberg JR, Hu XF, Ching M, Wakeling A, Wall DM, Marschner IC, de Luise M. Zalcberg JR, et al. Cancer Chemother Pharmacol. 1993;33(2):123-9. doi: 10.1007/BF00685329. Cancer Chemother Pharmacol. 1993. PMID: 7903222

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

358 results

Search Page

Filters